Bioversys 2021-04: Efficacy and Pharmacokinetics of novel test articles in a murine lung infection model withKlebsiella pneumoniae

Project Details

StatusFinished
Effective start/end date1/05/21 → 28/11/22

Funding

  • BioVersys AG: $104,721.48